Scientists test cancer drug safety in people with liver issues
NCT ID NCT05329623
Summary
This study aimed to understand how liver problems affect how the body processes a single dose of an experimental lung cancer drug called JDQ443. It compared 33 people with varying levels of liver impairment to healthy individuals, measuring drug levels in the blood over several days. The goal was to gather safety and dosing information for future studies in patients with both cancer and liver disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.